baber/WOPTO huggingface dataset:
Patent FI-920421-A0 (FI)
Inventor: HUPE JUERGEN
IPC: H05K3/42
Filed: 1992-01-30
Abstract: PCT No. PCT/EP90/01326 Sec. 371 Date Feb. 28, 1992 Sec. 102(e) Date Feb. 28, 1992 PCT Filed Aug. 11, 1990 PCT Pub. No. WO91/03920 PCT Pub. Date Mar. 21, 1991.A process is described for manufacturing through-hole plated single-layer or multi-layer printed circuit boards based on a polymeric substrate material or on a ceramic material provided optionally on both sides with at least one photoresist layer temporarily exposing the electroconductive circuit pattern by electroplating or electroless plating with a metal layer also on those surfaces which have not been coated with a conductive metal layer, characterized in that a) the surfaces of the substrate, after hole-drilling and a subsequent mechanical surface-treatment, are laminated with a suitable photoresist, exposed to light and developed so that the circuit pattern image is exposed, b) the surfaces of the substrate are pre-treated in a solution having oxidizing activity, c) after removal of the residual solution by rinsing, the substrate is introduced into a solution which contains at least one heterocyclic monomer, and more specifically pyrrole, thiophene, furane or derivative(s) thereof, which in a polymeric form is electrically conductive, d) the substrate is then transferred into an acidic solution whereby an electrically conductive polymeric layer is formed, whereupon, if desired or required, any residual solution is removed by rinsing, and the through-holes and the circuit pattern image are metallized in one step by galvanic or, preferably, electroless metallization.
Patent FI-920722-A0 (FI)
Inventor: CASTELLA SOLA JAUME
IPC: B01J27/02
Filed: 1992-02-19
Abstract: PCT No. PCT/FR91/00495 Sec. 371 Date Apr. 20, 1992 Sec. 102(e) Date Apr. 20, 1992 PCT Filed Jun. 20, 1991 PCT Pub. No. WO92/00264 PCT Pub. Date Jan. 9, 1992.The invention relates to a process for the synthesis of 1,1-bis(chlorophenyl)-2,2,2-trichloroethanol in (dicofol) from chlorol and chlorobenzene, in which process the acid by-products formed during the condensation reaction of the chloral and the chlorobenzene are used as reaction medium in the final step for synthesis of dicofol.
Patent FI-921191-A0 (FI)
Inventor: HAUPT ROBERT
IPC: B60T17/00
Filed: 1992-03-19
Abstract: The compressed air supply installation is intended especially for compressed air systems of vehicles. It comprises an oil-lubricated compressor (1) and units assigned to this, such as air cooler (1), oil separator (5), pressure regulator (6), air dryer (7) and air reservoir (8). At least some of these units are equipped with outlets (11-14) for condensate or air containing lubricating oil delivered during idling phases. All these outlets (11-14) are connected by lines (22-24) to a condensate collecting vessel (15) in which the condensate and lubricating oil are separated and collected. The air with the condensate and lubricating oil removed is released by way of a vent (26) into the environment. The environment is thereby at least largely relieved of the lubricating oil of the compressor (1) which in the case of known compressed air supply installations passed into the open air through their unit outlets. <IMAGE>
Patent FI-922189-A0 (FI)
Inventor: AALTONEN OLLI
IPC: C07D301/32
Filed: 1992-05-14
Abstract: The invention relates to a method for the preparation of optically active derivatives of epoxypropionic acid from racemic mixtures. The racemic mixture to be separated is first dissolved in carbon dioxide and the obtained solution is then passed through a chromatographic column. In a third step, the desired optical isomer of the derivative of epoxypropionic acid is separated from the eluant.
Patent FI-923895-A0 (FI)
Inventor: VAN DEVENTER MATTIJS OSKAR
IPC: H04B10/272
Filed: 1992-08-31
Abstract: Optical reflective star device for transmitting signals between a plurality of transceivers, provided with a plurality of ports for distributing each signal supplied to one port over the other ports. The reflective star device comprises a plurality of star elements having a plurality of reflection branches and a plurality of through-connections between the star elements. An optical amplifier is disposed in at least one of the reflection branches and/or through-connections. <IMAGE>
Patent FI-934243-A0 (FI)
Inventor: FUNAKI MOTOKATSU
IPC: E04G17/065
Filed: 1993-09-27
Abstract: The present invention aims at providing a heat insulating support tool for a concrete wall, as well as a concrete wall structure using such support tool, whereby the problems relating to outside insulation performance, breakage of the support tool, joint filler filling work for a recess and the bolt member mounting accuracy can all be overcome, a finish member can be mounted using a fixing rod-like member as a support portion for the finish member without driving an anchor, and in mounting the finish member, the fixing rod-like member can be adjusted to an appropriate projection level in accordance with the thickness of the finish member used. The said heat insulating support tool comprises a pedestal member (2) and a fixing rod-like member (3), the pedestal member (2) having a through-hole (7) extending from a surface portion (2a) which abuts the back of a front-side form up to a back portion, the said through-hole (7) having a hole portion on the back side (2b) which hole portion (9) is larger in inside diameter than the front portion, the fixing rod-like member (3) having a threaded portion (12) and a rotating portion (14) at an outside end thereof and having at an inside end thereof an enlarged head portion (10) smaller in diameter than the large-diameter hole portion (9), the outside end of the fixing rod-like member being protruded from the said through-hole to the surface portion, and a spacing holding rod-like member (17) which is embedded in concrete is connected to the inside end of the fixing rod-like member (3) in such a manner that the connection can be released by rotating the said rotating portion. The foregoing concrete wall structure is constituted by using the said support tool. <IMAGE>
Patent FI-944056-A0 (FI)
Inventor: JOENEMO PER
IPC: A47L15/14
Filed: 1994-09-02
Abstract: PCT No. PCT/SE93/00167 Sec. 371 Date Sep. 2, 1994 Sec. 102(e) Date Sep. 2, 1994 PCT Filed Feb. 26, 1993 PCT Pub. No. WO93/17610 PCT Pub. Date Sep. 16, 1993A cleaning machine operating with granules having a pump for ejecting liquid optionally with or without granules which are heavier than the liquid, through nozzles against the goods to be cleaned in a treatment space (10) connected to the suction side of the pump via a bottom outlet (11). A granule valve having a socket (38) open at each en thereof is associated with the bottom outlet, said socket being guided for vertical displacement between the upper position with an opening at the lower end of the socket for drawing liquid with granules entrained therein by the pump from the treatment space at a lower level, and a lower position with the opening at the lower ned of the socket closed for drawing liquid only by the pump from a higher level at the upper end of the socket. A projecting circumferential flange (49) is provided on the socket (38) below the upper end thereof said flange forming together with a cap (44) provided over the socket, a labyrinth seal for preventing granules from being withdrawn together with the liquid.
Patent FI-952114-A0 (FI)
Inventor: SU KAI C
IPC: B29C45/34
Filed: 1995-05-03
Abstract: A lens mold cavity is formed and then evacuated via a vacuum channel (3) contained within a mold member. A fluid valve (9) is opened to exposed the lens mold cavity to liquid lens material, whereby a vacuum of the lens mold cavity draws the liquid lens material to fill the lens mold cavity. The fluid valve is then closed and the liquid lens material within the lens mold cavity is cured to obtain an opthalmic lens such as a contact lens. <IMAGE>
Patent FI-956121-A0 (FI)
Inventor: ODEN AGNETA
IPC: A61C13/00
Filed: 1995-12-19
Abstract: The present invention relates to a method of manufacturing artificial tooth restorations for natural teeth or implants comprising a ceramic densely sintered high strength individual core (B) with dental porcelain (A) by powder metallurgical manufacturing methods. The inner surface (I) of the core (B), which will fit against one or more prepared tooth surfaces (P) or artificial abutments is manufactured by forming a ceramic powder mixture against a surface of a body at which said surface is manufactured by registering the surfaces of the prepared teeth or artificial abutments and their mutual relationship with a three dimensional optical or mechanical reading method directly in the mouth or on a model in e.g. plaster after which the registered surfaces are reproduced in an enlarged size e.g. with a computer controlled milling machine at which the enlargement is calculated from the shrinkage of the ceramic material during sintering to full density and considering the gap for cement.
Patent FI-961369-A0 (FI)
Inventor: FULLING FRANK
IPC: G06T9/00
Filed: 1996-03-25
Abstract: A method and device provide a unique and efficient scheme for utilizing a linked list data structure for encoding and decoding user data, thereby improving the efficiency and speed of data communication. In addition, processor use for computation is minimized, throughput delay is minimized, and throughput performance is maximized in a data communication system.
Patent FI-963871-A0 (FI)
Inventor: SPIRA JACK
IPC: A61K47/42
Filed: 1996-09-27
Abstract: PCT No. PCT/SE95/00348 Sec. 371 Date Sep. 17, 1996 Sec. 102(e) Date Sep. 17, 1996 PCT Filed Mar. 31, 1995 PCT Pub. No. WO95/26750 PCT Pub. Date Oct. 12, 1995The present invention relates to a pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration comprising coagulation factor VIII or factor IX and use thereof for manufacture of a medicament for treating haemophilia A or B. The formulation comprises coagulation factor VIII or factor IX with an activity of at least 200 IU/ml and an additive increasing the bio-availability of factor VIII or factor IX. Tests with factor VIII gives a therapeutic level of active factor VIII in the blood stream for a surprisingly long period of time after subcutaneous, intramuscular or intradermal administration. The factor VIII is suitably a highly purified recombinant factor VII, and preferably a deletion derivative thereof, which can be used for the manufacture of a medicament for subcutaneous administration.
Patent AP-8700058-A0 (AP)
Title: Building block
Inventor: SMIT ALBIN JAMES
Filed: 1987-02-20
Abstract: A building block 10 has an upper surface 16 which comprises a horizontal central portion 20, a pair of horizontal outer portions 22, and a pair of flanking portions 24 each extending at a relatively large angle to the horizontal from a respective one of the lateral edges of the central portion to the inner edge of the respective outer portion. Bottom surface 18 of the building block has a complimentary arrangement of central portion, outer portions, and flanking portions, so that when such building blocks are placed one on top of the other, they interlock, with the central, outer, and flanking portions of adjacent bottom and top surfaces being parallel to, and meeting, one another. A modified building block is privided for t-junctions and corners.
Patent IL-62322-A0 (IL)
Title: Preparation of 1,1-dichloro-alkenes
IPC: C07C61/40
Filed: 1981-03-09
Abstract: A process for the preparation of a 1,1-dichloroalkene of the formula <IMAGE>   in which R1 is hydrogen, or an optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, aralkyl, aralkenyl or aryl radical, and R2 is an optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, aralkyl, aralkenyl or aryl radical, or R1 and R2 together form an optionally branched and/or optionally benzo-fused hydrocarbon chain, comprising reacting a carbonyl compound of the formula <IMAGE>  with a trichloromethanephosphonic acid ester of the formula <IMAGE>  in which R3 each individually is an alkyl or phenyl radical, or the two radicals R3 together are alkanediyl, in the presence of at least an equimolar amount of a phosphorous acid triamide of the formula P(NR42)3 in which R4 each independently is an alkyl radical, or the two radicals R4 together are alkanediyl. Advantageously, R1 is hydrogen, R2 a C2 to C5 alkenyl radical, or a radical of the formula <IMAGE>  Z is a cyano, acetyl, carboxyl or C1 to C4 alkoxycarbonyl radical, or a radical of the formula -COOM, M is sodium or potassium, and R3 each individually is a C1 to C4 alkyl or phenyl radical, or the two radicals R3 together are C2 to C5 alkandiyl, the phosphorous acid triamide is phosphorous acid tris-dimethylamide or tris-diethylamide, about 0.94 to 1.1 moles of each of trichloromethanephosphonic acid ester and of the phosphorous acid triamide are employed per mole of the carbonyl compound, and the reaction is effected at about 10 DEG  to 100 DEG  C. in a polar aprotic solvent.
Patent IL-62915-A0 (IL)
Title: Process and device for separating mixtures of matter in the liquid phase
IPC: B01D3/14
Filed: 1981-05-20
Abstract: In a process for separating mixtures of matter in the liquid phase and a device suitable therefor, liquid (12) absorbs heat during its passage through a first cavity (3), said heat having been generated during the condensation yielding the condensate (13) at the upper wall portion (5) of the first cavity. The thus preheated liquid is passed to a third cavity (9), the upper wall portion (10) of which is liquid-tight and gas-tight and absorbs the thermal radiation (11). Part of the liquid further heated by said process evaporates and penetrates in vapor form through the liquid-tight, steam-permeable upper wall portion (8) of the third cavity (9) into a second cavity (6), the upper wall portion (8) of which is one and the same as the lower wall portion (9) of the third cavity. This steam condenses under the cooling action of the first cavity (3). The condensate (13) so formed is withdrawn from the second cavity. The cavities (1) and (3) are advantageously contained in double fabrics provided with adequate coatings and the two fabrics of which are spaced apart by means of spacers in the form of filaments.
Patent FI-20001841-A0 (FI)
Inventor: PAASONEN SIMO
IPC: E05B63/12
Filed: 2000-08-21
Abstract: A door lock, comprising a housing-like lock case (1) provided with a front plate (3) and including a hook bolt (4;5,6), which is movable between a locking and a releasing position by means of a key (9) of the lock or other force transmission element and comprises a linearly movable guiding part (5) and a separate hook part (6) turnably journalled on the end thereof and which is arranged in cooperation with a striking plate (14) in a door frame (13) so that in its locking position the hook part (6) of the hook bolt (4; 5, 6) is moved through an opening (14a) in the striking plate and is turned towards an inner surface (14b) in the striking plate. The hook bolt (4; 5, 6) comprises a pivot arrangement by means of which the hook part (6) is movable with regard to the guiding part (5) in the longitudinal direction of the front plate (3). In addition the lock case (1) includes a guiding groove (8; 8a, 8b) for guiding the pivoting point of the hook part (6) both in the longitudinal direction of the front plate (3) and in the direction of movement of the guiding part (5).
Patent FI-20012196-A0 (FI)
Inventor: LAUREN PEKKA
IPC: E05B15/02
Filed: 2001-11-13
Abstract: A bolt casing end, opposite to the section (2a) extending beyond the cut-out (3c) in the frame, is shaped so as to allow the inserting of the bolt casing (2) through the cut-out in the frame (3,3a,3b). The section (2a), after being mounted in the frame, is arranged to extend only in one direction beyond the region of the cut-out (3c) in the longitudinal direction of the striking plate, and in such a manner that a space is left between the section (2a) and the striking plate.
Patent FI-20075340-A0 (FI)
Inventor: VIIKKI PAAVO
IPC: B60D/
Filed: 2007-05-10
Abstract: The invention relates to a coupling hook, which is intended to attach an implement to a tractor by means of a coupling ball (11). The body (1), includes a housing (25) for a catch mechanism and a coupling throat (27) arranged to receive particularly the said coupling ball (11) and a catch (2) rotating in the housing (25) for locking the coupling ball (11) into the coupling throat (27). In the free position, the catch (2) can rotate, thus permitting the coupling ball (11) to rise out of the coupling throat (27). The catch (2) is operated by an operating lever (3). The catch (2) is arranged to return the operating lever (3) to the locking position, when the coupling ball (11) rotates it as it rises out of the coupling throat.
Patent IL-105815-A0 (IL)
Title: Selective cell inactivation in blood
IPC: A61K41/00
Filed: 1993-05-27
Abstract: Treatment with a set of porphyrin compounds using a photodynamic therapy approach is able selectively to lower elevated levels of activated leukocytes in a leukocyte population. This is particularly helpful in subjects containing such elevated levels of T-cell subsets, such as HIV-infected subjects.
Patent IL-108486-A0 (IL)
Title: Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IPC: A61K31/495
Filed: 1994-01-31
Abstract: The present invention relates to 9H-indeno[1,2-b]pyrazin-3(4H)-ones and 9H-indeno[1,2-b]pyrazine-2,3(1H,4H)-diones or tautomeric forms thereof which are useful in treating neurological and psychiatric diseases based on the antagonism of the glycine binding site on the NMDA receptor complex.
Patent IL-115618-A0 (IL)
Title: Polyolefin compositions exhibiting heat resistivity, low hexane-extractives and controlled modulus
IPC: C08L23/16
Filed: 1995-10-13
Abstract: The subject invention provides a polymer mixture having high heat resistivity, low hexane extractive and controllably lower or higher modulus. The mixture is comprised of at least one first substantially linear ethylene polymer, Component (A), and at least one second ethylene polymer which is a homogeneously branched polymer, heterogeneously branched linear polymer or a non-short chain branched linear polymer. When fabricated into film, the mixture is characterized by a heat seal initiation temperature which is substantially lower than its Vicat softening point as well as a high ultimate hot tack strength. When fabricated as a molded article, the mixture is characterized by high microwave warp distortion while maintaining a lower modulus. The polymer mixture is particularly well-suited for use in multilayer film structures as a sealant layer for such applications as cook-in packages, hot-fill packages, and barrier shrink films. In molding applications, the mixture is well-suited as freezer-to-microwave food storage containers and lids which maintain good flexibility at low temperature to allow easy openability of such containers.
Patent IL-144650-A0 (IL)
Title: Syringe pumps
IPC: F04B9/02
Filed: 2001-07-31
Abstract: A syringe pump has a motor 9 rotating a leadscrew 8 to drive a plunger head actuator 10 along it. The head actuator 10 engages the plunger 35 of a syringe 3 and moves the plunger along the syringe barrel 30 to dispense medication. An optical encoder 20 mounted on the leadscrew 8 is rotated by the motor 9 to produce a pulse output. A control unit 11 times the interval between the pulses and compares these timings with a stored value representative of a predetermined multiple of the minimum time. If the head actuator 10 is obstructed, the speed of rotation of the motor 9 is slowed and the time interval between pulses rises. When this exceeds the stored value, the control unit 11 stops the drive to the head actuator 10 and generates an alarm. <IMAGE>
Patent IL-150977-A0 (IL)
Title: A method for maintaining or improving the synthesis of mucins
IPC: A23L1/30
Filed: 2001-01-31
Abstract: Methods for maintaining, improving or increasing the synthesis of mucins by administering a nutritional composition or supplement that contains a therapeutically effective amount of threonine are provided. The present invention further provides methods for treating a variety of disease states characterized by alterations to the mucin levels, such as, intestinal inflammatory and bacterial infections or other like disease states.
Patent IL-151448-A0 (IL)
Title: Proteins
IPC: A61P35/00
Filed: 2001-02-21
Abstract: The present invention provides methods and compositions for screening, diagnosis and prognosis of breast cancer, for monitoring the effectiveness of breast cancer treatment, and for drug development.
Patent IL-158373-A0 (IL)
Title: Collapsible reformer exercise apparatus
IPC: A63B21/055
Filed: 2002-04-08
Abstract: A reformer exercise apparatus comprises a rectangular frame, a movable carriage mounted on the frame for supporting a user, and an elongated elastic member extending between the frame and the movable carriage for biasing the carriage toward the one end of the frame. The telescopic rectangular frame has a first frame section and a second frame section that each includes two spaced apart parallel tubular rail members. One set of rail members is telescopically received in the other set of rail members so that the frame is selectively movable between a first storage position and an extended operating position.
Patent IL-166296-A0 (IL)
Title: Aggregate with light-weight granular stone for theproduction of concrete as well as a method for it s production
IPC: C04B18/02
Filed: 2005-01-13
Abstract: An aggregate comprises a hydraulic binder mixture containing ash with a calcium oxide content of 10-20 wt.%, and additive(s). An independent claim is also included for the production of the aggregate.
Patent IL-166401-A0 (IL)
Title: Pharmaceutical compositions containing endothelialer
IPC: A61K38/19
Filed: 2005-01-20
Abstract: Use of erythropoetin (EPO) and/or its derivatives for stimulating, in endothelial precursor cells (EPC), any of physiological mobilization; proliferation; differentiation to endothelial cells and/or migration, in the direction of an angiogenic or vasculogenic stimulus. Independent claims are also included for the following: (1) use of EPO and/or its derivatives for stimulating formation of endothelial cells (EC) and/or for vasculogenesis; (2) use of EPO to produce a transplantable EC product; (3) use of EPO for treating a tissue or organ transplant; (4) use of EPO for pretreatment of tissue or organ transplants; (5) use of EPO to prepare implantable or transplantable, cell-containing in vitro organ or tissue systems; (6) use of EPO for coating vascular prostheses or heart valves; and (7) pharmaceutical composition containing (a) EPO, its derivatives, analogs, modifications or muteins and (b) at least one of vascular endothelial growth factor, PIGF (not defined), granulocyte-macrophage colony-stimulating factor and/or a hydroxymethyl glutarate-CoA reductase inhibitor. ACTIVITY : Antilipemic; Antidiabetic; Antiinflammatory; Antiarteriosclerosis; Cardiant; Vasotropic; Antianginal; Gynecological; Hypotensive; Nephrotropic. No details of tests for any of these activities are given. MECHANISM OF ACTION : Treatment with EPO increases adhesion of EPC and stimulates formation of endothelial tissue and blood vessels.